Alto Neuroscience is a provider of mental health treatment drugs. It is mainly engaged in the research and application of AI predictive antidepressants, and measures the condition by analyzing the patient’s EEG activity, behavioral performance and health data. The product is suitable for depression, trauma Post-stress disorder and other mental health conditions. Recently, Alto Neuroscience completed a $25 million B+ round of financing, the investor is Alpha Wave Ventures.
This article is transferred from: https://www.itjuzi.com/investevent/13792741
This site is only for collection, and the copyright belongs to the original author.